The pattern recognition receptor toll-like receptor (TLR)-4 mediates innate danger signaling in the brain, being activated in response to lipopolysaccharide. Until now, its role in the degenerating brain remained unknown. We here examined effects of a loss-of-function mutation of TLR-4 in mice submitted to transient focal cerebral ischemia and retinal ganglion cell (RGC) axotomy, which are highly reproducible and clinically relevant in vivo models of acute and subacute neuronal degeneration. We show that TLR-4 deficiency protects mice against ischemia and axotomy-induced RGC degeneration. Decreased phosphorylation levels of the mitogen-activated kinases ERK-1/-2, JNK-1/-2 and p38 together with reduced inducible NO synthase levels in injured neurons of TLR-4 mutant mice suggests that TLR-4 deficiency downscales parenchymal stress responses, thereby enhancing neuronal survival. At the same time, densities of MPO+ neutrophils and Iba1+ microglial cells were increased in the brains of TLR-4 mutant animals, pointing towards a futile inflammatory response aiming to compensate lost functions. Our data indicate that innate immunity may represent an attractive target for neuroprotective treatments in stroke and neurodegeneration.
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The injured brain is particularly vulnerable to environmental stimuli. As such, brain cells may remain viable under conditions of ischemia or trauma, but activate death programs when exposed to additional stressors, such as organic toxins (Hermann et al., 2006) or pro-inflammatory signals (Bermpohl et al., 2005) . To protect itself from injury, the brain has developed its own endogenous strategies.
Along the blood-brain barrier (BBB), so-called ATP-binding cassette (ABC) transporters are expressed on capillary cells that actively eliminate natural compounds from the brain (Begley, 2004; Löscher and Potschka, 2005; Hermann, and Bassetti, 2007) . ABC transporters are specifically regulated in response to ischemia (Spudich et al., 2006) and other kinds of brain injury (Hermann et al., 2006; Hermann, and Bassetti, 2007) , thus providing a highly efficacious barrier for environmental toxins.
In the surrounding of brain capillaries, perivascular dendritic and macrophages are located, which together with brain-resident microglia represent an innate surveillance system in the immuneprivileged brain (Bechmann et al., 2007) . This task is achieved by so-called pathogen-recognition receptors (PRR), which recognize conserved microbial motifs (Sansonetti, 2006; Sutmuller et al., 2006; Lee and Kim, 2007) .
Among the pathogen-associated molecular patterns (PAMP) recognized by brain-resident microglia, lipopolysaccharides (LPS), i.e., cell wall constituents of gram-negative bacteria, play a very important role, being detected by a PRR termed toll-like receptor (TLR)-4 (Chakravarty and Herkenham, 2005) . TLR-4 is a leucine-rich transmembrane protein, named after the toll protein in Drosophila, where this receptor family was first described (Lemaitre et al., 1996) .
Once stimulated by LPS, TLR-4 activates a variety of signal pathways in the cytosol of immune cells. Via its cytosolic Toll/ interleukin-1 (IL-1) receptor homology domain (TIR), TLR-4 stimulates mitogen-activated protein (MAP) and stress kinases, such as extracellular-regulated kinase (ERK)-1/-2, Jun kinase (JNK)-1/-2 and p38, which in turn activate transcription regulators of inflammation in the nucleus (Schröder et al., 2001 ). Activation of TLR-4 enables microglial cells to remove LPS from the brain tissue (Sutmuller et al., 2006) .
In view of the complex downstream responses activated by LPS we wondered how TLR-4 deactivation influences cell injury under conditions in which neurons are lost. We therefore investigated the www.elsevier.com/locate/ynbdi Neurobiology of Disease 31 (2008) 33 -40
